Cargando…

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15

Detalles Bibliográficos
Autor principal: van de Winkel, J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833833/
http://dx.doi.org/10.1186/ar843
_version_ 1782178479433842688
author van de Winkel, J
author_facet van de Winkel, J
author_sort van de Winkel, J
collection PubMed
description
format Text
id pubmed-2833833
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28338332010-03-08 Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15 van de Winkel, J Arthritis Res Ther Oral Presentation BioMed Central 2003 2003-09-12 /pmc/articles/PMC2833833/ http://dx.doi.org/10.1186/ar843 Text en
spellingShingle Oral Presentation
van de Winkel, J
Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title_full Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title_fullStr Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title_full_unstemmed Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title_short Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
title_sort candidate targets for antibody therapy of rheumatoid arthritis: cd64 and il-15
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833833/
http://dx.doi.org/10.1186/ar843
work_keys_str_mv AT vandewinkelj candidatetargetsforantibodytherapyofrheumatoidarthritiscd64andil15